Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

Overview of attention for article published in BMC Cancer, August 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 17,359 followers.

RT @ChrisHeery: This problem is not just intervention specific. It is indication specific as well. I will continue to make the case for vol…

05 Feb 2019

Reply Repost Favourite

This problem is not just intervention specific. It is indication specific as well. I will continue to make the case for volumetric imaging as the standard for @ChordomaFDN https://t.co/zzfR8dobWQ

05 Feb 2019

Reply Repost Favourite

RT @ChrisHeery: Enjoyed this project a lot. Volume vs. RECIST in @ChordomaFDN #openaccess https://t.co/6MRdJBXyf2

07 Sep 2016

Reply Repost Favourite

RT @ChrisHeery: Enjoyed this project a lot. Volume vs. RECIST in @ChordomaFDN #openaccess https://t.co/6MRdJBXyf2

04 Sep 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.